+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pazopanib"

Chondrosarcoma Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Chondrosarcoma Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • April 2023
  • 137 Pages
  • Global
From
Middle East and Africa Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Middle East and Africa Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 90 Pages
  • Middle East, Africa
From
Oncology Drugs Market Size, Share & Industry Trends Analysis Report By Indication, By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy and Hormonal Therapy), By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

Oncology Drugs Market Size, Share & Industry Trends Analysis Report By Indication, By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy and Hormonal Therapy), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • November 2023
  • 306 Pages
  • Global
From
Metastatic Cancer Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Indication, By Therapy (Targeted Therapy, Immunotherapy, Hormonal Therapy and Chemotherapy), By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

Metastatic Cancer Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Indication, By Therapy (Targeted Therapy, Immunotherapy, Hormonal Therapy and Chemotherapy), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • July 2023
  • 290 Pages
  • Global
From
Pazopanib API Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Pazopanib API Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 118 Pages
  • Global
From
Loading Indicator

Pazopanib is an oncology drug used to treat certain types of cancer. It is a tyrosine kinase inhibitor, meaning it works by blocking the action of certain enzymes that are involved in the growth and spread of cancer cells. Pazopanib is used to treat advanced renal cell carcinoma, a type of kidney cancer, and advanced soft tissue sarcoma, a type of cancer that affects the connective tissues. It is also used to treat other types of cancer, such as ovarian cancer and thyroid cancer. Pazopanib is available in tablet form and is taken orally. It is usually taken once daily, with or without food. Common side effects of pazopanib include nausea, vomiting, diarrhea, fatigue, and hair loss. Some companies in the pazopanib market include GlaxoSmithKline, Novartis, and Pfizer. Show Less Read more